A novel dicentric chromosome, dic(9;9)(p12;q34), leading to trisomy 9 in follicular lymphoma without t(14;18)

Leukemia Research

Volumn 35, Issue 7, 2011, Pages

  Yamamoto, Katsuya ^a   Matsuoka, Hiroshi ^a   Funakoshi, Yohei ^a   Yakushijin, Kimikazu ^a   Okamura, Atsuo ^a   Itoh, Tomoo ^a   Minami, Hironobu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ABL1 GENE; ADULT; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CDKN2A GENE; CHROMOSOME 9; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; DICENTRIC CHROMOSOME; FOLLICULAR LYMPHOMA; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; INGUINAL LYMPH NODE; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; TRISOMY; TRISOMY 9;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, FOLLICULAR; MALE; PROGNOSIS; TRANSLOCATION, GENETIC; TRISOMY;

EID: 79958723776     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.02.017     Document Type: Letter

References (10)

1. Knutsen T. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surv 1997, 30:163-192.
2. Horsman D.E., Okamoto I., Ludkovski O., Le N., Harder L., Gesk S., et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol 2003, 120:424-433.
3. Leich E., Salaverria I., Bea S., Zettl A., Wright G., Moreno V., et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 2009, 114:826-834.
4. Tagawa H., Karube K., Guo Y., Takeshita M., Kikuchi M., Morishima Y., et al. Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma. Leukemia 2007, 21:2549-2551.
5. Karube K., Ying G., Tagawa H., Niino D., Aoki R., Kimura Y., et al. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol 2008, 21:973-978.
6. An Q., Wright S.L., Konn Z.J., Matheson E., Minto L., Moorman A.V., et al. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci USA 2008, 105:17050-17054.
7. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer 2010; Updated on November 22, 2010. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman. [Accessed November 25, 2010].
8. Krenacs L., Himmelmann A.W., Quintanilla-Martinez L., Fest T., Riva A., Wellmann A., et al. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 1998, 92:1308-1316.
9. Bacher U, Haferlach C. +9 or trisomy 9. Atlas Genet Cytogenet Oncol Haematol. September 2006. URL: http://AtlasGeneticsOncology.org/Anomalies/tri9ID1020.html.
10. Wlodarska I., Pittaluga S., Stul M., Martiat P., Dierlamm J., Michaux L., et al. Philadelphia-like translocation t(9;22)(q34:q11) found in a follicular lymphoma involving not BCR and ABL but IGL-mediated rearrangement of an unknown gene on 9q34. Genes Chromosomes Cancer 1997, 20:113-119.